Literature DB >> 15090721

Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study.

Debbie A Lawlor1, George Davey Smith, Shah Ebrahim.   

Abstract

OBJECTIVE: To assess the association between fasting insulin levels and breast cancer.
DESIGN: Cross sectional study. PARTICIPANTS: 3868 women aged 60-79 years. MAIN OUTCOME MEASURE: Prevalent breast cancer (151 cases).
RESULTS: Insulin levels were positively associated with breast cancer. The age adjusted odds ratio (95% confidence interval) for a one unit increase in log(e) insulin levels among women without diabetes was 1.34 (1.02, 1.77). This association was not substantively altered by adjustment for potential confounding factors (age of menopause, hysterectomy/oophorectomy, hormone replacement use, oral contraceptive use, parity, adult social class and smoking) or potential mediating factors (body mass index, waist to hip ratio, leg length, age at menarche and childhood social class). Women with both long legs and higher insulin levels were at particularly increased risk, with breast cancer prevalence being 5.7% among women in the highest thirds of both insulin levels and leg-length compared to 1.8% among those in the lowest thirds of both. Positive associations between insulin levels and breast cancer were found for both pre- and post-menopausal breast cancers. Fasting glucose levels, HOMA score, diabetes and a history of gestational glycosuria or diabetes were also positively associated with breast cancer
CONCLUSIONS: Hyperinsulinaemia is positively associated with breast cancer in this cohort of older women. This effect may be mediated via a number of hormonal pathways acting at different stages of the life course. Copyright 2004 Kluwer Academic Publishers

Entities:  

Mesh:

Year:  2004        PMID: 15090721     DOI: 10.1023/B:CACO.0000024225.14618.a8

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  57 in total

1.  Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Authors:  Debora Macis; Sara Gandini; Aliana Guerrieri-Gonzaga; Harriet Johansson; Paolo Magni; Massimiliano Ruscica; Matteo Lazzeroni; Davide Serrano; Massimiliano Cazzaniga; Serena Mora; Irene Feroce; Maria Pizzamiglio; Maria Teresa Sandri; Marcella Gulisano; Bernardo Bonanni; Andrea Decensi
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

Review 2.  Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.

Authors:  Carlo La Vecchia; Sharon H Giordano; Gabriel N Hortobagyi; Bruce Chabner
Journal:  Oncologist       Date:  2011-05-31

3.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

Review 4.  Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer.

Authors:  Darren Micallef; Sarah Micallef; Pierre Schembri-Wismayer; Jean Calleja-Agius
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

5.  Childbearing recency and modifiers of premenopausal breast cancer risk.

Authors:  Neeraja B Peterson; Yifan Huang; Polly A Newcomb; Linda Titus-Ernstoff; Amy Trentham-Dietz; Gabriella Anic; Kathleen M Egan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

6.  Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss.

Authors:  José Manuel Fernández-Real; Javier A Menendez; Gema Frühbeck; José María Moreno-Navarrete; Alejandro Vazquez-Martín; Wifredo Ricart
Journal:  Nutr Metab (Lond)       Date:  2010-02-25       Impact factor: 4.169

Review 7.  Metabolic syndrome and cancer.

Authors:  Pooja Pothiwala; Sushil K Jain; Subhashini Yaturu
Journal:  Metab Syndr Relat Disord       Date:  2009-08       Impact factor: 1.894

8.  Breast cancer risk factors in Turkish women--a University Hospital based nested case control study.

Authors:  Vahit Ozmen; Beyza Ozcinar; Hasan Karanlik; Neslihan Cabioglu; Mustafa Tukenmez; Rian Disci; Tolga Ozmen; Abdullah Igci; Mahmut Muslumanoglu; Mustafa Kecer; Atilla Soran
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

Review 9.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

10.  Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women.

Authors:  Majed S Alokail; Nasser M Al-Daghri; Omar S Al-Attas; Tajamul Hussain
Journal:  Cardiovasc Diabetol       Date:  2009-06-23       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.